Oncogenic fusions JAK up CD8+ cytotoxic CTCL
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
Oncogenic fusions JAK up CD8+ cytotoxic CTCL. / Buus, Terkild B.; Koralov, Sergei B.
In: Blood, Vol. 138, No. 23, 2021, p. 2311-2312.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Buus, TB & Koralov, SB 2021, 'Oncogenic fusions JAK up CD8+ cytotoxic CTCL', Blood, vol. 138, no. 23, pp. 2311-2312. https://doi.org/10.1182/blood.2021013619
APA
Buus, T. B., & Koralov, S. B. (2021). Oncogenic fusions JAK up CD8+ cytotoxic CTCL. Blood, 138(23), 2311-2312. https://doi.org/10.1182/blood.2021013619
Vancouver
Buus TB, Koralov SB. Oncogenic fusions JAK up CD8+ cytotoxic CTCL. Blood. 2021;138(23):2311-2312. https://doi.org/10.1182/blood.2021013619
Author
Bibtex
@article{965e348b27224c8b9c546ef499860f3e,
title = "Oncogenic fusions JAK up CD8+ cytotoxic CTCL",
author = "Buus, {Terkild B.} and Koralov, {Sergei B.}",
note = "Funding Information: Conflict-of-interest disclosure: The authors declare no competing financial interests.",
year = "2021",
doi = "10.1182/blood.2021013619",
language = "English",
volume = "138",
pages = "2311--2312",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "23",
}
RIS
TY - JOUR
T1 - Oncogenic fusions JAK up CD8+ cytotoxic CTCL
AU - Buus, Terkild B.
AU - Koralov, Sergei B.
N1 - Funding Information: Conflict-of-interest disclosure: The authors declare no competing financial interests.
PY - 2021
Y1 - 2021
U2 - 10.1182/blood.2021013619
DO - 10.1182/blood.2021013619
M3 - Comment/debate
C2 - 34882212
AN - SCOPUS:85120739129
VL - 138
SP - 2311
EP - 2312
JO - Blood
JF - Blood
SN - 0006-4971
IS - 23
ER -
ID: 306681920